Injectable semaglutide and tirzepatide have been extensively studied in large clinical weight loss programs, and the once-weekly schedule is well established
So, at this time, we reserve our highest recommendation for forms and dosages that are most supported by current research
Additionally, if your Graves' disease treatment brings your thyroid hormones into normal range, your metabolic rate will stabilize, and tirzepatide dosing may need adjustment to avoid excessive weight loss
Even modest weight loss (510% of body weight) can improve metabolic hormone dynamics
Stomach pain thats especially severe or simply wont go away is cause for concern, too
A recent Everyday HealthYouGov online survey of nearly 3,000 U.S